Business
MedX Health Announces Change in Financing
Funding to Support US and International Distributor Agreements Remains Priority MISSISSAUGA, ON, ...
About this update from Medx Health Corp.
[{"type":"text","content":"\n\n\n\nFunding to Support US and International Distributor Agreements Remains\n\n\nPriority\n\n\nMISSISSAUGA, ON, July 16 /CNW/ - MedX Health Corp. (TSXV: MDX) ("MedX" or\nthe "Company") today announced that it has discontinued its financing\nrelationship with Research Capital, the firm that had begun their second round\nof financing in May 2008. The low level laser therapy device manufacturer\ncontinues to seek funding to help achieve the original goal of expanding its\ncommercialization plans.\n\n\n"We plan to efficiently close out this next round of financing as we\ncontinue to grow our product line and business opportunities." said Steve\nGuillen, president & chief executive officer. "The recently announced\ndistribution partnerships with Technology4Medicine, along with our recent\nexpansion internationally via a new network of worldwide distributors, are\nevidence of our commitment to become a global leader in low level laser\ntherapy," said Mr. Guillen.\n\n\nAbout MedX Health Corp.\n\n\nMedX is a leading North American developer and manufacturer of low level\nlaser medical devices, including dental, rehabilitation and wound care\nproducts. MedX is the world's only company focusing on developing and\ndelivering a broad cross-section of technologies and products involved in\nhealing using light therapy. MedX is committed to advocating for and bringing\nthe non-invasive, drug-free healing nature of light to people seeking relief\nfrom pain and other physical ailments.\n\n\nMedX's strategy is to build upon its success in bringing relief of\nsymptoms in a non-pharmacologic manner in the rehabilitation market through\nkey partnerships, acquisitions, strong patent protection as well as developing\nand commercializing advanced products in the dental and wound-care markets\nthat will position the company to increase revenue. In addition, MedX plans to\naccelerate the development of a new product aimed at the rapidly-growing wound\ncare market: its "Photobandage", a bandage technology that allows a wound to\nbe bathed in light, designed to enhance the healing process. The Company\nintends to license this new technology to one or more major wound care\ncompanies for further development of marketing and sales.\n\n\nThe TSX Venture Exchange does not accept responsibility for the ad...